Global Ezetimibe Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ezetimibe Market Research Report 2024
Ezetimibe is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone (marketed as Zetia or Ezetrol), when other cholesterol-lowering medications are not tolerated, or together with statins (e.g., ezetimibe/simvastatin, marketed as Vytorin or Inegy) when statins alone do not control cholesterol.
According to Mr Accuracy reports new survey, global Ezetimibe market is projected to reach US$ 460.8 million in 2029, increasing from US$ 315 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ezetimibe market research.
Key manufacturers engaged in the Ezetimibe industry include Merck, Teva, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Alkem Laboratories, APOTEX, Sandoz, Glenmark Pharmaceuticals and Mylan Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ezetimibe were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ezetimibe market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ezetimibe market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merck
Teva
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Alkem Laboratories
APOTEX
Sandoz
Glenmark Pharmaceuticals
Mylan Pharmaceuticals
Aurobindo Pharma
Accord Healthcare
Segment by Type
5mg
10mg
20mg
40mg
80mg
Adult
Children
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ezetimibe report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Ezetimibe market is projected to reach US$ 460.8 million in 2029, increasing from US$ 315 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ezetimibe market research.
Key manufacturers engaged in the Ezetimibe industry include Merck, Teva, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Alkem Laboratories, APOTEX, Sandoz, Glenmark Pharmaceuticals and Mylan Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ezetimibe were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ezetimibe market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ezetimibe market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Teva
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Alkem Laboratories
APOTEX
Sandoz
Glenmark Pharmaceuticals
Mylan Pharmaceuticals
Aurobindo Pharma
Accord Healthcare
Segment by Type
5mg
10mg
20mg
40mg
80mg
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ezetimibe report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source